Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • Businesses Solutions • FinTech (& Financials services) • A.I. (& Big Data) • HealthTech (& Fitness) • Cloud Services (& Infrastructure) • Developer tools • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Payments • Healthcare (& Wellness) |
Stages | Pre-Seed, Seed, Series A |
Investing | United States • Canada |
Investment Range | $250,000 - $2,000,000 |
Investment Sweet Spot | $1,000,000 |
Healthy Ventures is a purpose-built, early-stage venture investor focused on health tech, headquartered at 1 Letterman Drive Building C, Floor P, Suite 500, San Francisco, CA 94129, United States. They specialize in making high-conviction investments in health tech, often targeting companies that are infrastructural solutions, enabling technologies to scale healthcare with enterprise- and developer-facing products. Their approach to investing is selective, looking to identify key areas within the healthcare market that are attractive yet often overlooked. Healthy Ventures puts a strong emphasis on solutions that can overcome both the technical and commercial challenges to scaling in the healthcare sector. By maintaining a tight focus, they aim to unpack and address Go-to-Market challenges which they see as critical hurdles that many health tech founders encounter. They do not spread their efforts too thin but choose to concentrate on ripe, untapped opportunities. Their investment strategy includes vigorous understanding of healthcare and broader markets, facilitating productive conversations, bringing go-to-market resources to accelerate market adoption, and providing access to their robust network of customers, advisors, and talent to support founders. Their investment sizes range from a minimum of $250,000 to a maximum of $2,000,000, with a sweet spot of around $1,000,000, and they typically engage in Pre-Seed, Seed, and Series A funding rounds. Healthy Ventures is interested in companies that have infrastructural solutions that allow regulated industries to scale faster, and they expect these companies to have monetizable applications with core value coming from the infrastructure they build for future audacious actions. Notably, they avoid investments in consumer products, hardware, and consumer-facing health/wellness. The fund's key values include asymmetric focus, self-awareness, curiosity and rigor, and agency—these philosophies drive their partnership and investment decisions.
We invest in infrastructural solutions that enable technologies to scale healthcare. These are often enterprise- and developer-facing products.